In osteosarcoma, WTAP inhibits the expression of its potential target gene HMBOX1 through participation in m6A modification, significantly accelerating osteosarcoma development by regulating the PI3K/AKT pathway [39]. The gene discussed is AKT1; the disease is osteosarcoma.